Effects of raloxifene on bone mineral density and biochemical markers of bone remodeling in postmenopausal women pre-treated with raloxifene or alendronate for one year.

被引：0
|
作者：
Brown, J
Ng, KW
Toss, G
Zhou, C
Wong, M
Draper, MW
机构：
[1] Ctr Hosp Univ Quebec, Ste Foy, PQ, Canada
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[4] Lilly Res Labs, Indianapolis, IN USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [21] Using in postmenopausal women with bone mass loss raloxifene and alendronate
    Bazarra, A
    Castro, A
    Suarez, M
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S172 - S172
  • [22] Effects of raloxifene on bone mineral density, bone metabolism and serum lipids in healthy Chinese postmenopausal women
    Zheng, S
    Wu, Y
    Zhang, Z
    Yang, X
    Hui, Y
    Chen, S
    Deng, W
    Liu, H
    Ekangaki, A
    Liu, J
    BONE, 2003, 32 (05) : S218 - S218
  • [23] EFFECT OF ZOLEDRONIC ACID COMPARED TO RALOXIFENE ON BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Simon, James A.
    Bachmann, Gloria
    Warren, Michelle
    Kemp, Charisse
    Kianifard, Farid
    Goncalves, Joana
    Kriegman, Audrey
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S204 - S205
  • [24] Effects of raloxifene on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis
    Liu, J
    Zhu, H
    Huang, Q
    Zhang, Z
    Li, H
    Qin, Y
    Zhang, Y
    Wei, D
    Liu, Y
    Ekangaki, A
    BONE, 2003, 32 (05) : S217 - S217
  • [25] Effects of alendronate on bone mineral density and bone metabolic markers in postmenopausal asthmatic women treated with inhaled corticosteroids
    Kasayama, S
    Fujita, M
    Goya, K
    Yamamoto, H
    Fujita, K
    Morimoto, Y
    Kawase, I
    Miyatake, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (01): : 85 - 90
  • [26] Effects of Raloxifene on Bone Mineral Metabolism in Postmenopausal Japanese Women on Hemodialysis
    Tanaka, Motoko
    Itoh, Kazuko
    Matsushita, Kazunori
    Matsushita, Kazutaka
    Moriishi, Misaki
    Kawanishi, Hideki
    Fukagawa, Masafumi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 : 62 - 66
  • [27] Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis
    Ibrahim A. Abdelazim
    Khaled M. Abdelrazak
    Mohamed Al-Kadi
    Amr H. Yehia
    Bassam M. Sami Nusair
    Mohannad Abu Faza
    Archives of Osteoporosis, 2014, 9
  • [28] Effects of alfacalcidol on bone markers and bone mineral density in alendronate-treated postmenopausal women with osteopenia or osteoporosis: one year interim analysis of the ALFA study
    Boerst, H.
    Bock, O.
    Runge, M.
    Degner, C.
    Stephan-Oelkers, M.
    Umrath, F.
    Armbrecht, G.
    Martus, P.
    Schacht, E.
    Hashimoto, J.
    Felsenberg, D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S90 - S91
  • [29] Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis
    Abdelazim, Ibrahim A.
    Abdelrazak, Khaled M.
    Al-Kadi, Mohamed
    Yehia, Amr H.
    Nusair, Bassam M. Sami
    Abu Faza, Mohannad
    ARCHIVES OF OSTEOPOROSIS, 2014, 9 (01) : 189
  • [30] Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
    Delmas, PD
    Bjarnason, NH
    Mitlak, BH
    Ravoux, AC
    Shah, AS
    Huster, WJ
    Draper, M
    Christiansen, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23): : 1641 - 1647
12345